OPHLY and 4528:JP Related Headlines
Go Back- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY1,900 at JPMorgan
- Goldman Sachs Reiterates Sell Rating on Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY)
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY2,500 at Jefferies
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY2,100 at Goldman Sachs
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY1,900 at Goldman Sachs
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY1,800 at JPMorgan
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY2,400 at Nomura/Instinet
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY1,500 at JPMorgan
- UBS Starts Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) at Buy
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY2,200 at Citi
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY2,200 at Citi
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY1,800 at Nomura/Instinet
- Ono Pharmaceutical Co., Ltd (4528:JP) (OPHLY) PT Raised to JPY1,750 at Citi

